Philippine Clinical Practice Guidelines for Dengue
I cannot provide specific Philippine dengue clinical practice guidelines from the evidence provided, as the available documents primarily contain U.S. CDC diagnostic testing recommendations for dengue and Zika virus 1.
What the Evidence Shows
The research indicates significant heterogeneity exists among dengue clinical practice guidelines across different countries, including Southeast Asian nations 2, 3. A 2022 study specifically examining five Southeast Asian countries (Myanmar, Philippines, Vietnam, Indonesia, Cambodia) found considerable variation in:
- Dengue algorithms incorporated into IMCI guidelines
- Classification schemes for dengue severity
- Diagnostic approaches distinguishing dengue from other febrile illnesses
- Warning signs for progression to severe dengue 4
Most countries in the region maintain stand-alone clinical guidelines for dengue that are not integrated into broader clinical frameworks 4.
Key Limitations Identified
The available evidence reveals several critical gaps in dengue guideline implementation across the Philippines and similar settings:
- Inaccessibility of guidelines to frontline healthcare providers
- Lack of adequate training on guideline application
- Insufficient staffing to correctly implement guidelines
- Limited availability of diagnostic testing at peripheral facilities 3
Clinical Implications
While I cannot provide the specific Philippine dengue CPG content, clinicians should:
- Seek the official Department of Health (DOH) Philippines dengue guidelines directly from the Philippine DOH or Philippine Society of Microbiology and Infectious Diseases
- Be aware that laboratory testing should be offered early in the course of febrile illness, not delayed until day 3 of consecutive fever, as this approach misses approximately 36% of dengue cases in children 4
- Recognize that dengue classification schemes vary significantly between countries, affecting case management approaches 3
The methodological quality of dengue CPGs globally is highly variable, with only 6 out of 29 guidelines reviewed (2009-2025) rated as high quality, and only 3 of these using GRADE methodology 2.